
APi Group Corporation
APG
Updated: 24/09/2026, 08:33:43
APi Group Corporation operates as a global enterprise offering vital safety, specialized infrastructure, and industrial services across North America, Europe, Australia, and the Asia-Pacific region. Its business activities are segmented into three primary divisions: Safety Services, Specialty Services, and Industrial Services. The Safety Services division delivers comprehensive safety solutions, with a particular focus on integrated occupancy systems. This encompasses the full lifecycle of services for fire protection, heating, ventilation, and air conditioning (HVAC), and entry systems, from their initial design and installation to ongoing inspection, monitoring, and maintenance. The Specialty Services segment is dedicated to the upkeep and enhancement of critical infrastructure, including subterranean electric, gas, water, sewer, and telecommunications networks, as well as specialized industrial facilities. This segment's offerings span a broad range of services, including engineering, design, fabrication, installation, and the modernization or upgrading of existing systems. Within the Industrial Services segment, APi Group provides a variety of solutions primarily to the energy industry, emphasizing transmission and distribution. Its services include the construction of pipeline infrastructure, access roads, and supporting facilities, alongside integrity management and maintenance to ensure the longevity and reliability of these assets. The company serves a diverse clientele that spans both public and private sectors. This extensive customer base includes commercial, industrial, and manufacturing operations, fulfillment and distribution centers, educational and healthcare institutions, telecommunications firms, utility providers, high-tech companies, entertainment venues, retailers, financial service organizations, and governmental entities. Formed in 1926, APi Group Corporation adopted its current name in October 2019, having previously been known as J2 Acquisition Limited. The company's corporate headquarters are situated in New Brighton, Minnesota.
No summaries found.
- Share price
- $37.82
- Market cap
- $16.34B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Russell A. Becker
- Employees
- 29,000
- IPO date
- 29/04/2020
- Beta
- 1.599
- Last dividend
- $0.00
- Day range
- $37.56 – $38.19
- 52-week range
- $33.40 – $49.99
- 1-day performance
- 0.16%
- 1-year performance
- 13.23%
- Current drawdown (1Y)
- -24.34%
- CIK
- 0001796209
- CUSIP
- 00187Y100
- ISIN
- US00187Y1001
- Created
- 07/12/2025, 02:06:54
- Last update
- 24/09/2026, 08:33:43
Track APi Group Corporation with an AI analyst
See which prediction-market events move APG, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Kennedy Wilson and APG Form €2 Billion Residential Joint Venture to Develop and Manage over 3,400 Private Rented Homes in Ireland
Business Wire • STOCK • 04/06/2026, 05:01:00
APi Group Corporation (APG) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Seeking Alpha • STOCK • 03/06/2026, 17:11:57
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
GlobeNewsWire • STOCK • 31/05/2026, 21:30:00
APi Group Announces Participation in Upcoming Investor Conferences
Business Wire • STOCK • 20/05/2026, 09:30:00
APi Group Announces Closing of Previously Announced Financing Transactions
Business Wire • STOCK • 15/05/2026, 09:30:00
APi (APG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research • STOCK • 30/04/2026, 12:35:55
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
GlobeNewsWire • STOCK • 21/04/2026, 22:00:00
APi (APG) Soars 5.3%: Is Further Upside Left in the Stock?
Zacks Investment Research • STOCK • 20/04/2026, 18:16:05
APi Group Announces the Acquisition of Wtech Fire Group
Business Wire • STOCK • 17/04/2026, 09:30:00
Apogee Therapeutics Announces Positive Phase 2 Part A 52-Week Data of Zumilokibart (APG777), Demonstrating Maintenance and Deepening of Responses with Every 3- and 6-Month Dosing in Moderate-to-Severe Atopic Dermatitis
GlobeNewsWire • STOCK • 23/03/2026, 07:30:00
Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026
GlobeNewsWire • STOCK • 22/03/2026, 20:51:00
APi Group Corporation (APG) Presents at JPMorgan Industrials Conference 2026 Transcript
Seeking Alpha • STOCK • 17/03/2026, 11:12:25